These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27995086)

  • 1. Hepatocellular Carcinoma: The Role of Interventional Oncology.
    Donadon M; Solbiati L; Dawson L; Barry A; Sapisochin G; Greig PD; Shiina S; Fontana A; Torzilli G
    Liver Cancer; 2016 Nov; 6(1):34-43. PubMed ID: 27995086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons of Radiofrequency Ablation, Microwave Ablation, and Irreversible Electroporation by Using Propensity Score Analysis for Early Stage Hepatocellular Carcinoma.
    Wada T; Sugimoto K; Sakamaki K; Takahashi H; Kakegawa T; Tomita Y; Abe M; Yoshimasu Y; Takeuchi H; Itoi T
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar complication rates for irreversible electroporation and thermal ablation in patients with hepatocellular tumors.
    Verloh N; Jensch I; Lürken L; Haimerl M; Dollinger M; Renner P; Wiggermann P; Werner JM; Zeman F; Stroszczynski C; Beyer LP
    Radiol Oncol; 2019 Mar; 53(1):116-122. PubMed ID: 30840591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible electroporation versus radiofrequency ablation for hepatocellular carcinoma: a single centre propensity-matched comparison.
    Freeman E; Cheung W; Ferdousi S; Kavnoudias H; Majeed A; Kemp W; Roberts SK
    Scand J Gastroenterol; 2021 Aug; 56(8):942-947. PubMed ID: 34057003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on Percutaneous Local Ablative Procedures for the Treatment of Hepatocellular Carcinoma.
    Luerken L; Haimerl M; Doppler M; Uller W; Beyer LP; Stroszczynski C; Einspieler I
    Rofo; 2022 Oct; 194(10):1075-1086. PubMed ID: 35545102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study.
    Zheng H; Liu K; Yang Y; Liu B; Zhao X; Chen Y; Feng Y; Meng M; Tan X; Zhu Q
    Eur Radiol; 2022 Jul; 32(7):4657-4666. PubMed ID: 35092477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
    An C; Li WZ; Huang ZM; Yu XL; Han YZ; Liu FY; Wu SS; Yu J; Liang P; Huang J
    Eur Radiol; 2021 Jul; 31(7):4764-4773. PubMed ID: 33399908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Incomplete Irreversible Electroporation (IRE) and Microwave Ablation (MWA) of Hepatocellular Carcinoma (HCC) Using Iodine Quantification in Dual Energy Computed Tomography (DECT).
    Bäumler W; Beyer LP; Lürken L; Wiggermann P; Stroszczynski C; Dollinger M; Schicho A
    Diagnostics (Basel); 2022 Apr; 12(4):. PubMed ID: 35454034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of radiofrequency ablation and ablative external radiotherapy for the treatment of intrahepatic malignancies: A hybrid meta-analysis.
    Rim CH; Lee JS; Kim SY; Seong J
    JHEP Rep; 2023 Jan; 5(1):100594. PubMed ID: 36561128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irreversible electroporation of hepatocellular carcinoma: the role of ultrasonography.
    Sugimoto K; Abe M; Yoshimasu Y; Takeuchi H; Kasai Y; Itoi T
    Ultrasonography; 2020 Jul; 39(3):229-237. PubMed ID: 32450674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher Efficiency of Percutaneous Microwave (MWA) Than Radiofrequency Ablation (RFA) in Achieving Complete Response in Cirrhotic Patients with Early Hepatocellular Carcinoma.
    Gaia S; Ciruolo M; Ribaldone DG; Rolle E; Migliore E; Mosso E; Vola S; Risso A; Fagoonee S; Saracco GM; Carucci P
    Curr Oncol; 2021 Feb; 28(2):1034-1044. PubMed ID: 33669107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microwave ablation versus radiofrequency ablation as bridge therapy in potentially transplantable patients with single HCC ≤ 3 cm: A propensity score-matched study.
    Wang X; Yu H; Zhao F; Xu Y; Wang C; Liu K; Liu B; Zheng H; Wei Y; Wang X; Zhu Q; Huang M; Feng Y
    Eur J Radiol; 2023 Jul; 164():110860. PubMed ID: 37178491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous radiofrequency versus microwave ablation for management of hepatocellular carcinoma: a randomized controlled trial.
    Kamal A; Elmoety AAA; Rostom YAM; Shater MS; Lashen SA
    J Gastrointest Oncol; 2019 Jun; 10(3):562-571. PubMed ID: 31183208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of local ablative therapies, including radiofrequency ablation, microwave ablation, stereotactic ablative radiotherapy, and particle radiotherapy, for inoperable hepatocellular carcinoma: a systematic review and meta-analysis.
    Cheng PL; Wu PH; Kao WY; Lai YT; Hsu JC; Chiou JF; Wu MH; Lee HL
    Exp Hematol Oncol; 2023 Apr; 12(1):37. PubMed ID: 37046292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image-guided locoregional non-intravascular interventional treatments for hepatocellular carcinoma: Current status.
    Qian K; Zhang F; Allison SK; Zheng C; Yang X
    J Interv Med; 2021 Feb; 4(1):1-7. PubMed ID: 34805939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis.
    Tan W; Deng Q; Lin S; Wang Y; Xu G
    Int J Hyperthermia; 2019; 36(1):264-272. PubMed ID: 30676100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of radiofrequency and microwave ablation and identification of risk factors for primary treatment failure and local progression.
    McDevitt JL; Collard MD; Murphy RP; Sutphin PD; Yopp AC; Singal AG; Kalva SP
    Clin Imaging; 2020 Nov; 67():146-151. PubMed ID: 32659600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review and meta-analysis of local ablative therapies for resectable colorectal liver metastases.
    Di Martino M; Rompianesi G; Mora-Guzmán I; Martín-Pérez E; Montalti R; Troisi RI
    Eur J Surg Oncol; 2020 May; 46(5):772-781. PubMed ID: 31862133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.
    Frühling P; Nilsson A; Duraj F; Haglund U; Norén A
    Eur J Surg Oncol; 2017 Apr; 43(4):751-757. PubMed ID: 28109674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimally invasive local therapies for liver cancer.
    Li D; Kang J; Golas BJ; Yeung VW; Madoff DC
    Cancer Biol Med; 2014 Dec; 11(4):217-36. PubMed ID: 25610708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.